Subscribe To
Why shares of phathom pharmaceutical jumped this week
Investors are reading between the lines to see if the company is fixing its problems regarding its lead therapy....
January 28, 2023, 1:58 pm
Rosen, a globally recognized firm, encourages phathom pharmaceuticals, inc. investors to inquire about securities class action investigation – phat
NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securiti...
January 17, 2023, 11:50 pm
phathom pharmaceuticals announces positive topline results from phase 3 phalcon-nerd-301 trial evaluating daily dosing of vonoprazan for symptomatic non-erosive gastroesophageal reflux disease (nerd)
Both vonoprazan 10 mg and 20 mg doses met the primary endpoint and showed highly statistically significant greater percentage of 24-hour heartburn fre...
January 8, 2023, 11:00 pm
phathom (phat) down on regulatory update on vonoprazan nda
phathom Pharmaceuticals, Inc. (PHAT) declines as the FDA decides to not take any action on ...
January 5, 2023, 12:02 pm
Rosen, a leading, longstanding, and top ranked firm, encourages phathom pharmaceuticals, inc. investors to inquire about securities class action investigation – phat
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securiti...
November 23, 2022, 11:07 pm
phathom pharmaceuticals reports third quarter 2022 financial results and provides business updates
Patient enrollment completed for Phase 3 non-erosive gastroesophageal reflux disease (NERD) daily dosing trial with topline data for primary endpoint ...
November 8, 2022, 10:00 pm
phathom pharmaceuticals to present at the h.c. wainwright 24th annual global investment conference
FLORHAM PARK, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a ...
September 7, 2022, 8:15 am
phathom pharmaceuticals to present at the 21st annual needham virtual healthcare conference
FLORHAM PARK, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a ...
April 1, 2022, 8:01 am
phathom pharma's digestive disease candidate meets primary goal in mid-stage study
phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonop...
February 10, 2022, 10:02 am
phathom pharma's digestive disease candidate meets primary goal in mid-stage study
phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonop...
February 10, 2022, 10:02 am
phathom pharma's digestive disease candidate meets primary goal in mid-stage study
phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonop...
February 10, 2022, 10:02 am
phathom pharmaceuticals: undiscovered gem
phathom Pharmaceuticals: Undiscovered Gem...
January 20, 2022, 1:00 am
phathom pharmaceuticals: undiscovered gem
phathom Pharmaceuticals: Undiscovered Gem...
January 20, 2022, 1:00 am
phathom pharmaceuticals: undiscovered gem
phathom Pharmaceuticals: Undiscovered Gem...
January 20, 2022, 1:00 am